Philips Doubles Down On ESG And AI While Servicing Respironics Recall Priority

Company Agrees Terms Of US Consent Decree And CEO Remains Bullish On Outlook

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.